EP0671929A4 - Compositions. - Google Patents

Compositions.

Info

Publication number
EP0671929A4
EP0671929A4 EP93923917A EP93923917A EP0671929A4 EP 0671929 A4 EP0671929 A4 EP 0671929A4 EP 93923917 A EP93923917 A EP 93923917A EP 93923917 A EP93923917 A EP 93923917A EP 0671929 A4 EP0671929 A4 EP 0671929A4
Authority
EP
European Patent Office
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93923917A
Other languages
German (de)
French (fr)
Other versions
EP0671929A1 (en
Inventor
Panayiotis Peri Constantinides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0671929A1 publication Critical patent/EP0671929A1/en
Publication of EP0671929A4 publication Critical patent/EP0671929A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
EP93923917A 1992-10-16 1993-10-15 Compositions. Withdrawn EP0671929A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96295692A 1992-10-16 1992-10-16
US962956 1992-10-16
PCT/US1993/009915 WO1994008603A1 (en) 1992-10-16 1993-10-15 Compositions

Publications (2)

Publication Number Publication Date
EP0671929A1 EP0671929A1 (en) 1995-09-20
EP0671929A4 true EP0671929A4 (en) 1996-09-25

Family

ID=25506551

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93923917A Withdrawn EP0671929A4 (en) 1992-10-16 1993-10-15 Compositions.

Country Status (3)

Country Link
EP (1) EP0671929A4 (en)
JP (1) JPH08502490A (en)
WO (1) WO1994008603A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US5948825A (en) * 1993-04-19 1999-09-07 Institute For Advanced Skin Research Inc. Microemulsion preparation containing a slightly absorbable substance
HU215966B (en) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Oral multiple emulsion-preconcentrate containing cyclosporin
AU698317B2 (en) 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
DE69804624T2 (en) * 1997-07-29 2002-09-19 Upjohn Co SELF-TEMPERATURE FORMULATION CONTAINING LIPOPHILE COMPOUNDS
EP1039893B1 (en) 1997-12-10 2011-02-02 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
WO1999053941A1 (en) * 1998-04-15 1999-10-28 Shionogi & Co., Ltd. Oral preparations containing trh derivatives
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
IE990935A1 (en) * 1999-11-08 2002-04-03 Procter & Gamble Cosmetic Compositions
KR100508695B1 (en) * 2001-02-13 2005-08-17 한국과학기술연구원 Formulation for oral delivery of insulin and preparation method thereof
JP4251988B2 (en) 2001-12-14 2009-04-08 ヤーゴテック アクチェンゲゼルシャフト Pharmaceutical formulations containing cyclosporine and uses thereof
CA2560613C (en) 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
EP2438910A1 (en) 2004-08-31 2012-04-11 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2514406A1 (en) * 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
WO2013153000A2 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
CA2920110C (en) 2013-08-08 2022-05-31 Novan, Inc. Compositions and kits including a nitric oxide releasing compound and a hydrogel
CN106456541A (en) * 2014-02-14 2017-02-22 黄敬珺 Compositions of nanoemulsion delivery systems
EP3177262A4 (en) * 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
KR102319497B1 (en) 2016-03-02 2021-11-01 노반, 인크. Composition for treating inflammation and method for treating inflammation
HUE055231T2 (en) 2016-12-16 2021-11-29 Novo Nordisk As Insulin containing pharmaceutical compositions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (en) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Microemulsions
EP0387647A2 (en) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH High-dispersion pharmaceutical composition
WO1991018669A1 (en) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Process for preparing microemulsion
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
WO1993002665A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions
WO1993002664A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876765A (en) * 1968-05-03 1975-04-08 Choay Sa Pharmaceutical composition containing vitamin b' 12', process of making the same and method of treatment therewith

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (en) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Microemulsions
EP0387647A2 (en) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH High-dispersion pharmaceutical composition
WO1991018669A1 (en) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Process for preparing microemulsion
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
WO1993002665A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions
WO1993002664A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9408603A1 *

Also Published As

Publication number Publication date
JPH08502490A (en) 1996-03-19
WO1994008603A1 (en) 1994-04-28
EP0671929A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
ZA939656B (en) Microvicidal compositions.
EP0598412A3 (en) Skinprotection composition.
EP0621279A3 (en) Siloxy-aluminoxane compositions.
EP0671929A4 (en) Compositions.
EP0597463A3 (en) Thermotherapiesonde.
CY2493B1 (en) Aerosol compositions.
EP0605089A3 (en) Photoresist composition.
EP0580285A3 (en) Auto-reclosers.
IL110665A0 (en) Erection-inducing compositions
ZA937274B (en) Detergent composition.
ZA932689B (en) Disinfectant compositions.
EP0568827A3 (en) Photoimageable compositions.
GB9318641D0 (en) Compositions
ZA933068B (en) Detergent composition.
GB9215772D0 (en) Compositions
EP0572808A3 (en) Antiblocage-system.
GB9323313D0 (en) Clenasing compositions
GB9213059D0 (en) Compositions
EP0668864A4 (en) Substituted biphenylmethylimidazopyridines.
PH30815A (en) Composition.
GB9404236D0 (en) Cable-making compositions
EP0599191A3 (en) Speed-governor-circuit.
CY2411B1 (en) Compositions.
EP0592354A3 (en) Vacuum-centrifuge.
GB9210526D0 (en) Compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950510

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19960807

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19980925

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990206